Lucy Roalfe

1.0k total citations · 1 hit paper
19 papers, 668 citations indexed

About

Lucy Roalfe is a scholar working on Epidemiology, Microbiology and Immunology. According to data from OpenAlex, Lucy Roalfe has authored 19 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 9 papers in Microbiology and 4 papers in Immunology. Recurrent topics in Lucy Roalfe's work include Pneumonia and Respiratory Infections (17 papers), Respiratory viral infections research (12 papers) and Bacterial Infections and Vaccines (9 papers). Lucy Roalfe is often cited by papers focused on Pneumonia and Respiratory Infections (17 papers), Respiratory viral infections research (12 papers) and Bacterial Infections and Vaccines (9 papers). Lucy Roalfe collaborates with scholars based in United Kingdom, United States and Israel. Lucy Roalfe's co-authors include David Goldblatt, Marta Zancolli, Elizabeth Miller, Polly Burbidge, Nick Andrews, Emma Pearce, Shamez Ladhani, Pauline A. Waight, Mary Slack and Matthew D. Snape and has published in prestigious journals such as Journal of Clinical Microbiology, The Journal of Infectious Diseases and Infection and Immunity.

In The Last Decade

Lucy Roalfe

19 papers receiving 659 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study

2014 393 citations Nick Andrews, Pauline A. Waight et al. The Lancet Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lucy Roalfe United Kingdom	11	574	200	86	50	49	19	668
Heidi Åhman Finland	11	620 1.1×	399 2.0×	83 1.0×	48 1.0×	45 0.9×	15	686
Ray Borrow United Kingdom	14	557 1.0×	581 2.9×	66 0.8×	44 0.9×	43 0.9×	39	671
Anu Soininen Finland	12	698 1.2×	336 1.7×	93 1.1×	40 0.8×	42 0.9×	18	762
Lindsey Ashton United Kingdom	16	929 1.6×	557 2.8×	127 1.5×	72 1.4×	41 0.8×	20	1.0k
Laura J. York United States	16	504 0.9×	476 2.4×	49 0.6×	43 0.9×	42 0.9×	30	598
Cecilia Fazio Italy	16	515 0.9×	569 2.8×	79 0.9×	50 1.0×	40 0.8×	52	676
Paola Canepa Italy	15	307 0.5×	88 0.4×	52 0.6×	64 1.3×	41 0.8×	29	404
Eeva Pekkanen Finland	6	519 0.9×	440 2.2×	43 0.5×	66 1.3×	83 1.7×	7	656
Arianna Neri Italy	16	414 0.7×	463 2.3×	27 0.3×	40 0.8×	47 1.0×	55	579
Dorothee Kieninger Germany	11	680 1.2×	481 2.4×	86 1.0×	100 2.0×	42 0.9×	16	775

Countries citing papers authored by Lucy Roalfe

Since Specialization

Citations

This map shows the geographic impact of Lucy Roalfe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucy Roalfe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucy Roalfe more than expected).

Fields of papers citing papers by Lucy Roalfe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucy Roalfe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucy Roalfe. The network helps show where Lucy Roalfe may publish in the future.

Co-authorship network of co-authors of Lucy Roalfe

This figure shows the co-authorship network connecting the top 25 collaborators of Lucy Roalfe. A scholar is included among the top collaborators of Lucy Roalfe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucy Roalfe. Lucy Roalfe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Swarthout, Todd D., Thandie S. Mwalukomo, Arox W. Kamng’ona, et al.. (2024). Clonal Expansion of a Streptococcus pneumoniae Serotype 3 Capsule Variant Sequence Type 700 With Enhanced Vaccine Escape Potential After 13-Valent Pneumococcal Conjugate Vaccine Introduction. The Journal of Infectious Diseases. 230(1). e189–e198. 5 indexed citations

Kawade, Anand, Emma Pearce, Lucy Roalfe, et al.. (2023). Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (SynflorixTM and Prevenar13TM)) on nasopharyngeal carriage and serotype-specific immune response in the first two years of life: Results from an open-labelled randomized controlled trial in Indian children. Vaccine. 41(19). 3066–3079. 9 indexed citations

Goldblatt, David, Nick Andrews, Carmen Sheppard, et al.. (2023). Pneumococcal carriage following PCV13 delivered as one primary and one booster dose (1 + 1) compared to two primary doses and a booster (2 + 1) in UK infants. Vaccine. 41(19). 3019–3023. 7 indexed citations

Wolf, Asia‐Sophia, Elena Mitsi, Scott Jones, et al.. (2022). Quality of antibody responses by adults and young children to 13-valent pneumococcal conjugate vaccination and Streptococcus pneumoniae colonisation. Vaccine. 40(50). 7201–7210. 7 indexed citations

Buchwald, Ulrike K., Charles P. Andrews, John Ervin, et al.. (2021). Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older. Human Vaccines & Immunotherapeutics. 17(8). 2678–2690. 10 indexed citations

Madhi, Shabir A., Alane Izu, Sutika Bhikha, et al.. (2020). Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in South African children: an open-label, randomised, non-inferiority trial. The Lancet Infectious Diseases. 20(12). 1426–1436. 16 indexed citations

Jones, Scott, Lucy Roalfe, Suzanne Byrne, et al.. (2019). Assignment of Serotype-Specific IgG1, IgG2, and IgA Weight-Based Antibody Units to the Human Pneumococcal Standard Reference Serum, 007sp. mSphere. 4(3). 2 indexed citations

Balloch, Anne, Lucy Roalfe, Nina Ekström, et al.. (2018). Interlaboratory Comparison of the Pneumococcal Multiplex Opsonophagocytic Assays and Their Level of Agreement for Determination of Antibody Function in Pediatric Sera. mSphere. 3(2). 9 indexed citations

Goldblatt, David, Jo Southern, Nick Andrews, et al.. (2017). Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial. The Lancet Infectious Diseases. 18(2). 171–179. 68 indexed citations

10.

Urbančíková, Ingrid, et al.. (2017). Immunogenicity and safety of a booster dose of the 13-valent pneumococcal conjugate vaccine in children primed with the 10-valent or 13-valent pneumococcal conjugate vaccine in the Czech Republic and Slovakia. Vaccine. 35(38). 5186–5193. 13 indexed citations

11.

Adler, Adam S., Matthew Spindler, Matthew S. Adams, et al.. (2017). Rare, high-affinity anti-pathogen antibodies from human repertoires, discovered using microfluidics and molecular genomics. mAbs. 9(8). 1282–1296. 31 indexed citations

12.

Burton, Robert L., Joseph M. Antonello, David Cooper, et al.. (2017). Assignment of Opsonic Values to Pneumococcal Reference Serum 007sp for Use in Opsonophagocytic Assays for 13 Serotypes. Clinical and Vaccine Immunology. 24(2). 21 indexed citations

13.

Trück, Johannes, Sena Jawad, David Goldblatt, et al.. (2016). The Antibody Response Following a Booster With Either a 10- or 13-valent Pneumococcal Conjugate Vaccine in Toddlers Primed With a 13-valent Pneumococcal Conjugate Vaccine in Early Infancy. The Pediatric Infectious Disease Journal. 35(7). 787–793. 11 indexed citations

14.

Karlsson, Johanna, Lucy Roalfe, Harriet Hogevik, et al.. (2016). Poor Correlation between Pneumococcal IgG and IgM Titers and Opsonophagocytic Activity in Vaccinated Patients with Multiple Myeloma and Waldenstrom's Macroglobulinemia. Clinical and Vaccine Immunology. 23(4). 379–385. 15 indexed citations

15.

Blumental, Sophie, Jennifer C. Moïsi, Lucy Roalfe, et al.. (2015). Streptococcus pneumoniae Serotype 1 Burden in the African Meningitis Belt: Exploration of Functionality in Specific Antibodies. Clinical and Vaccine Immunology. 22(4). 404–412. 5 indexed citations

16.

Pearson, Frances E., David A. Muller, Lucy Roalfe, et al.. (2015). Functional anti-polysaccharide IgG titres induced by unadjuvanted pneumococcal-conjugate vaccine when delivered by microprojection-based skin patch. Vaccine. 33(48). 6675–6683. 17 indexed citations

17.

Tonder, Andries J. van, James E. Bray, Lucy Roalfe, et al.. (2015). Genomics Reveals the Worldwide Distribution of Multidrug-Resistant Serotype 6E Pneumococci. Journal of Clinical Microbiology. 53(7). 2271–2285. 23 indexed citations

18.

Moens, Leen, Bert Verbinnen, Kris Covens, et al.. (2015). Anti-Pneumococcal Capsular Polysaccharide Antibody Response and CD5 B Lymphocyte Subsets. Infection and Immunity. 83(7). 2889–2896. 6 indexed citations

19.

Andrews, Nick, Pauline A. Waight, Polly Burbidge, et al.. (2014). Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study. The Lancet Infectious Diseases. 14(9). 839–846. 393 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact